Author

Deanilee Deckard 1

1 Eli Lilly and Company,Indianapolis,United States

MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Paul F. Pollock, Theresa Hunter, Mingyang Shan, Lai Shan Chan, Deanilee Deckard, David T. Rubin

MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Edward V. Loftus, Paul Pollack, Theresa Hunter, Mingyang Shan, Deanilee Deckard, Raymond Cross, Lai Shan Chan

MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Miguel Regueiro, Mingyang Shan, Paul Pollack, Lai Shan Chan, Pieter Hindryckx, Theresa Hunter Gibble, Monika Fischer, David T. Rubin, Deanilee Deckard

Item 1 - 3 / 3
1